Back to Search
Start Over
Hypofractionated Radiotherapy in Localized, Low-Intermediate-Risk Prostate Cancer: Current and Future Prospectives.
- Source :
-
Medicina (Kaunas, Lithuania) [Medicina (Kaunas)] 2023 Jun 14; Vol. 59 (6). Date of Electronic Publication: 2023 Jun 14. - Publication Year :
- 2023
-
Abstract
- At the time of diagnosis, the vast majority of prostate carcinoma patients have a clinically localized form of the disease, with most of them presenting with low- or intermediate-risk prostate cancer. In this setting, various curative-intent alternatives are available, including surgery, external beam radiotherapy and brachytherapy. Randomized clinical trials have demonstrated that moderate hypofractionated radiotherapy can be considered as a valid alternative strategy for localized prostate cancer. High-dose-rate brachytherapy can be administered according to different schedules. Proton beam radiotherapy represents a promising strategy, but further studies are needed to make it more affordable and accessible. At the moment, new technologies such as MRI-guided radiotherapy remain in early stages, but their potential abilities are very promising.
Details
- Language :
- English
- ISSN :
- 1648-9144
- Volume :
- 59
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Medicina (Kaunas, Lithuania)
- Publication Type :
- Academic Journal
- Accession number :
- 37374348
- Full Text :
- https://doi.org/10.3390/medicina59061144